IPP Bureau
Sandoz launches generic lenalidomide in 19 countries across Europe
By IPP Bureau - February 18, 2022
Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines
Quotient Sciences integrates drug substance into Translational Pharmaceutics Platform
By IPP Bureau - February 18, 2022
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
Ribon Therapeutics appoints Prakash Raman as President and CEO
By IPP Bureau - February 18, 2022
Dr. Raman has succeeded Victoria Richon
Evonik invests in start-up to improve patient recovery after open-chest surgery
By IPP Bureau - February 18, 2022
Evonik invests in start-up to improve patient recovery after open-chest surgery
Medicx Health elevates Virginia Evans to Sr. VP
By IPP Bureau - February 18, 2022
Virginia will be responsible for meeting client needs for both media and commercial analytics.
Lyra Therapeutics appoints Harlan W. Waksal as Executive Chairman
By IPP Bureau - February 18, 2022
Waksal holds a successful track record of founding, scaling and advising growth-oriented companies.
Agilent acquires Virtual Control’s AI technology to enhance lab productivity
By IPP Bureau - February 18, 2022
Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis
Bayer raises peak sales for Nubeqa to exceed €3 billion
By IPP Bureau - February 18, 2022
Darolutamide is developed jointly by Bayer and Orion Corporation
Ligand posts strong 2021 performance
By IPP Bureau - February 18, 2022
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
AptarGroup reported 2021 sales at US $3.23 billion
By IPP Bureau - February 18, 2022
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
LEO Pharma appoints Brian Hilberdink President of LEO Pharma, US
By IPP Bureau - February 18, 2022
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
Moderna’s Covid-19 vaccine approved in Australia for children (6-11 years)
By IPP Bureau - February 17, 2022
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
IPP to organize e-conference on 'Indian Pharma Industry: Developing a conducive ecosystem' on Feb 18
By IPP Bureau - February 17, 2022
The speakers for the e-conference are: Dr. Mukund Chorgade, President/CSO, THINQ Pharma; Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance; Jayaseelan J., National Vice President (Industry Division), Indian Pharmaceutical Association; Spandan Mishra who is Director- Sales, Customer Service & Logistics for Evonik India, Nepal & Sri Lanka region; Dr. Kommu Nagaiah, Chief Scientist & Head, CSIR-IICT; Govind K. Jaju, Partner, Suingora Consulting; nd Pravin Prashant, Executive Editor, Indian Pharma Post & Editor, Indian Chemical News.
Center for Breakthrough Medicines launches analytical testing
By IPP Bureau - February 17, 2022
More than 2,500 submissions are currently under review in the Food and Drug Administration's (FDA) cell and gene therapy pipeline
Kato wins USFDA approval for studies in retinal disorder
By IPP Bureau - February 17, 2022
Resolv ER may remedy leading causes of blindness in adults
